TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT04802395: Real World Evidence Clinical Utility Study of KidneyIntelX

Sponsor: Renalytix AI, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 10000 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT04802395 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04802395 Rescue Dossier →